gabexate has been researched along with Air Embolism in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajitani, N | 1 |
| Hasui, T | 1 |
| Ishiyama, S | 1 |
| Shiode, J | 1 |
| Yamamoto, K | 1 |
| Takada, S | 1 |
| Itoshima, T | 1 |
1 other study available for gabexate and Air Embolism
| Article | Year |
|---|---|
[Hepatic portal venous gas--a report of two cases successfully treated with conservative management].
Topics: Aged; Cefozopran; Cephalosporins; Clindamycin; Colitis; Colonic Diseases; Drug Therapy, Combination; | 2004 |